Xtant Medical Expands Biologics Portfolio Through Distribution Relationship with Vivex Biomedical Inc

Saturday, March 26, 2016

Through agreement, Xtant Medical will be entering cellular bone graft market with a viable cell allograft, osteovive.

Vivex will process the allograft for Xtant Medical, and Xtant Medical will provide national distribution.

Says expanding its biologics portfolio through a distribution relationship with Vivex Biomedical, Inc.


Source : reuters.com